KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81 | -39.6% | 5,818 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $134 | +15.5% | 5,818 | +48.1% | 0.00% | 0.0% |
| Q1 2023 | $116 | -4.1% | 3,929 | -19.0% | 0.00% | 0.0% |
| Q4 2022 | $121 | -99.9% | 4,852 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $106,000 | +11.6% | 4,852 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | -59.9% | 4,804 | -14.2% | 0.00% | -50.0% |
| Q1 2022 | $237,000 | -69.1% | 5,602 | -53.6% | 0.00% | -33.3% |
| Q4 2021 | $766,000 | +113.4% | 12,076 | +97.4% | 0.00% | 0.0% |
| Q3 2021 | $359,000 | +35.5% | 6,117 | +12.0% | 0.00% | +50.0% |
| Q2 2021 | $265,000 | – | 5,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |